Mylan

Mylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylan's Global President and…

Currently Mylan has 21 facilities and 15,000 employees working in India Multinational drug company Mylan will invest $1 billion…

The second eribulin brand in India, teceris aimed at expanding access to metastatic breast cancer patients in India

The second patent cliff is around the corner, as patents for branded molecules with cumulative global sales of over $ 251 billion…

FDD Conclave, a one-of-its-kind platform for formulation development and drug delivery professionals, is a thought leadership…

HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast…

The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand names

The event will focus on better health for a better world Mylan will host a health hackathon at its Global Center in Bengaluru on…

To create a leading Women's Healthcare Franchise

With this approval, FDI of $750 million will be received in the country The government has approved the proposal of global pharma…